G1 Therapeutics Stock (NASDAQ: GTHX) stock price, news, charts, stock research, profile.
Open | $4.150 |
Close | $4.280 |
Volume / Avg. | 690.097K / 1.365M |
Day Range | 4.090 - 4.350 |
52 Wk Range | 1.080 - 5.000 |
Market Cap | $223.413M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 5.33% |
Days to Cover | 2.74 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of G1 Therapeutics (NASDAQ: GTHX) through any online brokerage.
Other companies in G1 Therapeutics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM) and Inovio Pharmaceuticals (NASDAQ:INO).
The latest price target for G1 Therapeutics (NASDAQ: GTHX) was reported by Needham on Friday, April 12, 2024. The analyst firm set a price target for 12.00 expecting GTHX to rise to within 12 months (a possible 180.37% upside). 18 analyst firms have reported ratings in the last year.
The stock price for G1 Therapeutics (NASDAQ: GTHX) is $4.28 last updated Today at April 17, 2024 at 4:00 PM EDT.
There are no upcoming dividends for G1 Therapeutics.
G1 Therapeutics’s Q1 earnings are confirmed for Wednesday, May 1, 2024.
There is no upcoming split for G1 Therapeutics.
G1 Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.